Aktive Positionen von Cole Ikkala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01.07.2020 | - |
Karriereverlauf von Cole Ikkala
Ehemalige bekannte Positionen von Cole Ikkala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NVN LIQUIDATION, INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Cole Ikkala
- Erfahrung
